Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression.
D000818:Animals; D015820:Cadherins / Q000032:analysis; D002450:Cell Communication / Q000187:drug effects*; D045744:Cell Line, Tumor; D065131:Endothelin B Receptor Antagonists; D019332:Endothelin-1 / Q000494:pharmacology; D019334:Endothelin-3 / Q000494:pharmacology; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D053504:Matrix Metalloproteinases, Membrane-Associated; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008666:Metalloendopeptidases / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D011759:Pyrrolidines / Q000494:pharmacology; D044023:Receptor, Endothelin B / Q000502:physiology; D015398:Signal Transduction
C120508:A 192621; D015820:Cadherins; D065131:Endothelin B Receptor Antagonists; D019332:Endothelin-1; D019334:Endothelin-3; D011759:Pyrrolidines; D044023:Receptor, Endothelin B; D020928:Mitogen-Activated Protein Kinases; D053504:Matrix Metalloproteinases, Membrane-Associated; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9